Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Please include your organization in your Zoom name.
- Click on your picture/name in Zoom
- Click on rename
- enter <name> - <organization>
Name | Organization | Present |
---|---|---|
Jean Duteau (chair) | Duteau Design | x |
John Hatem | Independent Consultant | |
Jose Costa Teixeira | PATH | x |
Melva Peters | Jenaker Consulting | |
Scott Robertson (scribe) | Kaiser Permanente | x |
Name | Organization | Present |
---|---|---|
Danielle Bancroft | Best Practice Software | |
Christof Gessner | HL7 Germany | |
Corey Spears | MITRE | |
Dave Hill | MITRE | |
Frank McKinney | POCP | x |
Isaac Vetter | Epic | |
Joseph Quinn (Joe) | Smile Digital Health | |
Lawrence Lo | Columbia University HIT Student | |
Margaret Weiker | NCPDP | x |
Matt Szczepankiewicz | Epic | |
Peter Sergent | HL7 New Zealand | |
Reed D. Gelzer | Trustworthy EHR | |
Shelly Spiro | Pharmacy HIT Collaborative | x |
Stephen Chu | ADHA | x |
Tim McNeil | Surescripts | |
Kim Roberts | Pharmacy HIT Collaborative | |
Phung Matthews | 3M | |
Jack Brashier | Epic | |
Emmanuel Obasuyi | ||
Joel Montavon | PQA | |
Robb Young | PharmID | |
Christopher Isong | ||
Gary Schoettmer | NetRx | |
Courtney Bland | CVS / Aetna | |
Mark Neumuth | Aetna | |
Ed Millikan | FDA | |
Sanket Raval | CVS / Aetna | |
James Tcheng | ||
Peter Muir | ||
Joe Kelly | Surescripts | x |
Peter Jordan | ||
Giorgio Cangioli | HL7 Italy | x |
Jeff Shick | USP | |
Kent Bulza | Artera | |
Sarah Danielson | ||
Hans Buitendijk | x | |
Pooja Babbrah | POCP | x |
Agenda Items and Notes
Outstanding Action Item List
Meeting Notes from the previous meeting
- 2023-03-13 Meeting Notes - accepted by acclimation
Project Proposals
Project Proposals in Review - none to review
Project Scope Statements
Project Scope Statements - none to review
May WGM Draft Agenda Review
- - skipped
External Meeting Review
- - nothing to report
Catalog Updates (John Hatem)
- - No meeting last week
Workflow Update (John Hatem)
- - No update
Healthcare Product Update (John Hatem)
- - No update
EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)
- - No meeting this week, next meeting will be the first week of April.
Project updates
Pharmacy Templates
- - Giorgio has a Publication request document. It will be discussed and voted on in the March 20th meeting.
- Pharmacy Template STU2 - CDA Publication Request Checklist
- HL7 CDA Pharmacy Template STU2 (publication request)
- Based on this WG's review of the CDA Publication Checklist for this IG (Pharmacy Template STU2 - CDA Publication Request Checklist) and confirmation that no quality variations have been detected during the performed review, a motion has been made to approve the CDA IG Publication Request. Giorgio Cangioli / Jose Costa Teixeira: 10-0-0
Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)
- - in good shape. a number of things require input/work from other groups. remaining items are minor
Status state diagram review
- John reviewed the mapping between Med dispense status and BDP dispense status. Suggestion was to send this to the list serve for input.
- review of mapping document.
- "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
- BDP "allocated" description is "ready for transport"
- "returned" - we don't have it, do we need it (returned after picked up). usually these are wasted ... but can be reused in some cases.
- as opposed to "return to stock," which was "ready for pickup" and not received by patient.
- pharmacy "completed" - BDP says "issued"
- pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
- pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")
- "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
- - Need status update?
- John's working on it
- review of mapping document.
NCPDP Updates (NCPDP Members)
-
Specialty Medication Enrolment IG
- - Need status update - have all items below been completed?
- STU2 Publication Request - Specialty Medication Enrollment
- current version expires June 6, 2023
- needs to be reviewed by FHIR Management Group
- need to post the ballot comments spreadsheet and request withdrawal of negatives - Scott has submitted
- Frank should be the publishing facilitator
- #39 - should be yes
- Provide Lynn the updated Product Brief
- Motion to approve the publication request subject to action items above - Melva Peters - Frank McKinney - 8-0-0 Carried
- Frank will update and forward to FMG
- Frank reports in progress
- STU2 Publication Request - Specialty Medication Enrollment
Any Other Business
- USCDI - Shelly Spiro / Hans Buitendijk
- discuss USCDI during call today - dedicate about 30 minutes for the discussion. ( Scott reached out to Hans for overview - awaiting his response) also invite Margaret (for NCPDP side). send note to list
- Hans present. extended discussion on what USCDI is, what the current (v4) goal is, how are terms defined.
- USCDI is a set of data elements which are required for the certification of HIT systems. currently that means that all HIT systems must be able to support all USCDI elements, even those that do not pertain to specific scenarios. for example, Lab systems may not care about past procedures or medication instructions, but certification to USCDI would require lab systems support that information (e.g., store if received, send if present). Comments have been submitted to the regulatory process to provide flexibility to not require all USCDI elements for all systems.
- Medication Instructions - information to patient or care giver on how to take the medication (dose, interval, etc.). added in v4. Note this will initially just be a text string, but in the future should/could be fully encoded. Maps to MedicationRequest.dosageInstruction.text (FHIR US Core v5) and MedicationDispense..dosageInstruction.text (FHIR US Core v5).
- Medication Administration - record of mediation administrated to the patient. mostly for inpatient and clinic-administered meds. unlikely to be available for retail prescriptions. group is intereste in promoting to include in v4
- Quantity - the number of (doses) in a dispense. As opposed to the number of dosage units in each administration. (smr - I know we discussed this but I can't find it in USCDI).
- Hans present. extended discussion on what USCDI is, what the current (v4) goal is, how are terms defined.
- discuss USCDI during call today - dedicate about 30 minutes for the discussion. ( Scott reached out to Hans for overview - awaiting his response) also invite Margaret (for NCPDP side). send note to list
- Email from Floyd - pharmacy SIG questions
- will respond to Floyd - ask him to submit a Jira issue with specific examples and the value set that is being used
- https://childrens.health.qld.gov.au/wp-content/uploads/PDF/digital-future/qrg/Medication-scheduling-administration-times.pdf
- John responded to Floyd this morning. added supplement from our discussion